Rupeng Zhang

Rupeng Zhang

Auto-generated profile, based on publicly available information

Rupeng Zhang

Department of Gastric Surgery, Tianjin Medical University Cancer Institute & Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin Key Laboratory of Digestive Cancer; Tianjin’s Clinical Research Center for Cancer, Tianjin, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
JDJingyu Deng
Jingyu Deng
HLHan Liang
Han Liang
GYGuoguang Ying
Guoguang Ying
RZRupeng Zhang
Rupeng Zhang
BWBaogui Wang
Baogui Wang
XHXishan Hao
Xishan Hao
RNF 180, a novel tumor suppressor, has been implicated in the carcinogenesis and progress of gastric cancer. At present study, we found that lower expression of RNA180 was specific in gastric cancer tissues, and the inconsistently methylated levels of RNF180 promoter were identified in the gastric cancer tissues. Importantly, we demonstrated that the methylated CpG site count and four hypermethylated CpG sites (-116, -80, +97, and +102) were significantly associated with the survival of 400 gastric cancer patients, respectively. With multivariate survival analyses, we demonstrated that both the methylation of combined CpG (-116, -80, +97, and +102) sites and N stage were the independent indictor of prognosis of gastric cancer patients. Eventually, the methylation of combined CpG (-116, -80, +97, and +102) sites was identified to have smaller AIC value than N stage by mean of AIC calculation with the Cox proportional hazards model. These findings indicated that the quantitative detection of RNF180 promoter methylation had the intensive feasibility for evaluation the prognosis of gastric cancer patients in clinic.

1 February 2021 in Electrochimica Acta
Verified
Journal Article
Closed access
RLRuinan Li
Ruinan Li
YLYaqi Li
Yaqi Li
RZRupeng Zhang
Rupeng Zhang
MHMengxue He
Mengxue He
YMYulin Ma
Yulin Ma
GYGeping Yin
Geping Yin

6 January 2024 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
FCFenglin Cai
Fenglin Cai
XYXiuding Yang
Xiuding Yang
GMGang Ma
Gang Ma
PWPengliang Wang
Pengliang Wang
MZMengmeng Zhang
Mengmeng Zhang
JDJingyu Deng
Jingyu Deng

16 April 2024 in Experimental Cell Research
Verified
Journal Article
Closed access
GMGang Ma
Gang Ma
SLSiya Liu
Siya Liu
FCFenglin Cai
Fenglin Cai
HLHan Liang
Han Liang
JDJingyu Deng
Jingyu Deng
MCMingzhi Cai
Mingzhi Cai

4 May 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
XWXinyu Wang
Xinyu Wang
PWPengliang Wang
Pengliang Wang
WWwei wang
wei wang
ZSZhe Sun
Zhe Sun
ZWZhenning Wang
Zhenning Wang
JDJingyu Deng
Jingyu Deng
Introduction: Lymph node (LN) stage is important for prognosis evaluation of gastric cancer (GC) patients. This study aimed to evaluate the prognostic value of the ratio of negative to positive LNs (Rnp) in GC. Methods: The authors evaluated the clinical significance of the Rnp stage in 7660 GC patients from three high-volume institutions in China. Meanwhile, the authors verified the value of the Rnp stage in 11 234 GC patients from the Surveillance, Epidemiology, and End Results (SEER) database. Results: The patients were stratified into different subgroups based on the N stage of the eighth edition of the TNM staging system, the ratio of positive to detected LNs (Rpd) and Rnp. The survival analysis showed clear differences between the three LN stages in both the China and Surveillance, Epidemiology, and End Results cohorts. In univariate and multivariate analyses, the Rnp stage provided smaller Akaike information criterion or Bayesian information criterion values and a larger likelihood ratio χ2 than the N or Rpd stages in both two cohorts. For patients with inadequate examined LNs (<16), the Rnp stage showed better prognostic evaluation performance than the other two stages. In addition, the 5-year disease-specific survival of GC patients showed a slight variation with increasing LNs in the same subgroup classified by the Rnp or Rpd stages compared to the N stage. Conclusions: Along with the higher prognostic value, the Rnp stage has excellent universality with GC patients compared to the N or Rpd stages. Studies with larger sample sizes are needed to predict the prognosis and provide more precise treatment for GC patients.

17 June 2026 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
JDJingyu Deng
Jingyu Deng
FCFenglin Cai
Fenglin Cai
MZMengmeng Zhang
Mengmeng Zhang
XNXinyang Nie
Xinyang Nie
MCMingzhi Cai
Mingzhi Cai
JDJingyu Deng
Jingyu Deng